Appeals Court Reinstates Antitrust Suit Over Taxol Generics
By Marius Meland ( June 27, 2004, 12:00 AM EDT) -- A U.S. appeals court has paved the way for Xechem International to seek treble damages in an antitrust suit against drug maker Bristol-Myers Squibb over its alleged efforts to thwart generic competition for the cancer drug Taxol....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.